Literature DB >> 2642527

Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies.

R Carter1, P M Graves, I A Quakyi, M F Good.   

Abstract

We have studied the antibodies to sexual stage antigens of Plasmodium falciparum in human sera from Papua New Guinea where intense transmission of P. falciparum occurs as well as the less prevalent P. malariae and P. vivax. In extracts of gametes of P. falciparum we have studied the reactivity of serum antibodies with antigens labeled with 125I on the surface of the gametes as well as intracellular gamete antigens. A prominent 27-kD sexual stage-specific intracellular protein was recognized more or less in proportion to the general antibody response to gamete proteins. The response to the gamete surface proteins, however, was quite unrepresentative of the general antibody response to the intracellular gamete proteins. No antibodies were detected against Pfs25, a 21-kD protein expressed on zygotes and ookinetes of P. falciparum and known to be a sensitive target of malaria transmission-blocking antibodies. The antibody response to two other target antigens of transmission-blocking antibodies on the surface of gametes of P. falciparum, a 230- and a 48- and 45-kD protein doublet, was very variable and independent of the response to the internal protein antigens. Several possibilities are discussed that may account for the variable response to these gamete surface antigens in individuals with otherwise good antibody responses to internal sexual stage proteins. Among these is the possibility that there is MHC restriction of the immune response to the gamete surface antigens in the human population. This interpretation accords well with evidence for MHC-restricted immune response to the same P. falciparum gamete surface antigens in studies with H-2 congenic mice (24).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642527      PMCID: PMC2189199          DOI: 10.1084/jem.169.1.135

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Successful immunization against the sexual stages of Plasmodium gallinaceum.

Authors:  R W Gwadz
Journal:  Science       Date:  1976-09-17       Impact factor: 47.728

2.  Plasmodium gallinaceum: exflagellation stimulated by a mosquito factor.

Authors:  M M Nijhout
Journal:  Exp Parasitol       Date:  1979-08       Impact factor: 2.011

3.  Plasmodium gallinaceum: transmission-blocking immunity in chickens. I. Comparative immunogenicity of gametocyte- and gamete-containing preparations.

Authors:  R Carter; R W Gwadz; F M McAuliffe
Journal:  Exp Parasitol       Date:  1979-04       Impact factor: 2.011

4.  Immunisation against gametes and asexual erythrocytic stages of a rodent malaria parasite.

Authors:  K N Mendis; G A Targett
Journal:  Nature       Date:  1979-02-01       Impact factor: 49.962

5.  Radioiodination of parasite antigens with 1,3,4,6-tetrachloro-3 alpha, 6 alpha-diphenylglycoluril (IODOGEN): studies with zygotes of Plasmodium gallinaceum.

Authors:  R J Howard; D C Kaushal; R Carter
Journal:  J Protozool       Date:  1982-02

6.  Complete in vitro maturation of Plasmodium falciparum gametocytes.

Authors:  T Ifediba; J P Vanderberg
Journal:  Nature       Date:  1981-11-26       Impact factor: 49.962

7.  A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies.

Authors:  C A Grotendorst; N Kumar; R Carter; D C Kaushal
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Biosynthesis of the target antigens of antibodies blocking transmission of Plasmodium falciparum.

Authors:  N Kumar; R Carter
Journal:  Mol Biochem Parasitol       Date:  1984-11       Impact factor: 1.759

9.  Malaria immunization in Rhesus monkeys. A vaccine effective against both the sexual and asexual stages of Plasmodium knowlesi.

Authors:  R W Gwadz; I Green
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum.

Authors:  J Rener; P M Graves; R Carter; J L Williams; T R Burkot
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

2.  Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity.

Authors:  B Wizel; N Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 3.  Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines.

Authors:  Ajay K Saxena; Yimin Wu; David N Garboczi
Journal:  Eukaryot Cell       Date:  2007-06-08

4.  Analysis of immunity induced by the affinity-purified 21-kilodalton zygote-ookinete surface antigen of Plasmodium berghei.

Authors:  N Tirawanchai; L A Winger; J Nicholas; R E Sinden
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

5.  Associations Between Helminth Infections, Plasmodium falciparum Parasite Carriage and Antibody Responses to Sexual and Asexual Stage Malarial Antigens.

Authors:  Ulysse Ateba-Ngoa; Sophie Jones; Jeannot Fréjus Zinsou; Josiane Honkpehedji; Ayola Akim Adegnika; Jean-Claude Dejon Agobe; Marguerite Massinga-Loembe; Benjamin Mordmüller; Teun Bousema; Maria Yazdanbakhsh
Journal:  Am J Trop Med Hyg       Date:  2016-06-06       Impact factor: 2.345

Review 6.  Transmission-Blocking Vaccines: Old Friends and New Prospects.

Authors:  Festus K Acquah; Joshua Adjah; Kim C Williamson; Linda E Amoah
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

7.  Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.

Authors:  Cevayir Coban; Ken J Ishii; Anthony W Stowers; David B Keister; Dennis M Klinman; Nirbhay Kumar
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.

Authors:  Cevayir Coban; Mario T Philipp; Jeanette E Purcell; David B Keister; Mobolaji Okulate; Dale S Martin; Nirbhay Kumar
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum.

Authors:  S P Chang; G S Hui; A Kato; W A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  A very large C-loop in EGF domain IV is characteristic of the P28 family of ookinete surface proteins.

Authors:  Babita Sharma; Rahul Dev Ambedkar; Ajay K Saxena
Journal:  J Mol Model       Date:  2008-12-05       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.